|
KMID : 1148920180520060462
|
|
Nuclear Medicine and Molecular Imaging
2018 Volume.52 No. 6 p.462 ~ p.467
|
|
|
Successful Localization Using 68Ga-DOTATOC PET/CT of a Phosphaturic Mesenchymal Tumor Causing Osteomalacia in a Patient with Concurrent Follicular Lymphoma
|
|
Ha Se-Jin
Park Su-Jin
Kim Hyun-Ji
Go Heoun-Jeong
Lee Seung-Hun
Choi Ji-Yoon
Hong Jung-Yong
Ryu Jin-Sook
|
|
|
Abstract
|
|
|
|
Diagnosing tumor-induced osteomalacia is often challenging because conventional imaging modalities may fail to locate the responsible tumor. This report describes the ability of 68Ga-DOTATOC PET/CT to successfully distinguish between the responsible phosphaturic mesenchymal tumor and concurrent lymphoma lesions. A 52-year-old man with bone pain for several years was diagnosed with a vitamin D-resistant hypophosphatemic osteomalacia. Whole body 18F-FDG PET/CT revealed multiple enlarged hypermetabolic lymph nodes in his bilateral cervical, axillary, mediastinal, abdominal, pelvic, and inguinal regions. Core needle biopsy of the right cervical lymph node confirmed the diagnosis of follicular lymphoma. However, lymphoma was not considered the cause of osteomalacia. 68Ga-DOTATOC PET/CT before chemotherapy showed a small nodule with intensely increased uptake in the right inguinal region, which was distinguished from the other enlarged lymph nodes. The nodule was surgically removed and histopathologically consistent with phosphaturic mesenchymal tumor. After surgery, the patient’s serum phosphorus and alkaline phosphatase levels normalized without nutritional supplement.
|
|
|
KEYWORD
|
|
|
PET/CT, 68Ga-DOTATOC, Hypophosphatemia, Oncogenic osteomalacia, Phosphaturic mesenchymal tumor
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|